Combined oral contraceptives and their impact on lipids, blood pressure, and body mass index in pregnant women
Keywords:
hormonal contraception, body mass index, blood pressure, women's health, reproductive health, lipid profile, oral contraceptive pillsAbstract
Objective: To determine how combination oral contraceptive pills (COCPs) affect women of reproductive age's lipid profiles, blood pressure, and body mass index. Methodology: This cross-sectional study looked at the family planning programmes at the tertiary referral hospitals in Peshawar. We looked at married, childbearing women (aged 14 to 49). Group 1 (those who had used COCPs for at least six months) and Group 2 (controls of a comparable age who had not used COCPs) were created. Fasting blood TC, TG, HDL-C, LDL-C, and VLDL-C levels were assessed using a chemical analyser. Hb and platelet levels were assessed by a haematology analyst. Everyone had their BMI and blood pressure measured. The parameters of the oral and control groups were compared using SPSS. Results: The average BMI of Group 1 (Oral COCP) was 28.12 kg/m2 (+/- 0.50 SEM), while the average BMI of Group 2 (Control) was 26.25 kg/m2 (+/- 0.43 SEM). The mean BMIs of the two groups were very different (p-value: 0.0003). Women in Group 1 who took combined oral contraceptives had a much higher BMI than women in Group 2 who did not. BMI is used to measure health. It is based on height and weight.
Downloads
References
Azmat, S. K., Ali, M., Ishaque, M., Mustafa, G., Hameed, W., Khan, O. F., ... & Munroe, E. (2015). Assessing predictors of contraceptive use and demand for family planning services in underserved areas of Punjab province in Pakistan: results of a cross-sectional baseline survey. Reproductive health, 12(1), 1-10.
Azmat, S. K., Shaikh, B. T., Hameed, W., Bilgrami, M., Mustafa, G., Ali, M., ... & Ahmed, A. (2012). Rates of IUCD discontinuation and its associated factors among the clients of a social franchising network in Pakistan. BMC women's health, 12(1), 1-8.
Christin-Maitre, S. (2013). History of oral contraceptive drugs and their use worldwide. Best practice & research Clinical endocrinology & metabolism, 27(1), 3-12.
Faryal, U., Jadoon, M., Shoukat, S., Ahmad, A., Rashid, S., & Shaheen, R. (2023). Effect of Combined Oral Contrraceptive Pills on Serum Total Cholesterol and Body Mass Index in Females of Reproductive Age Group. Pakistan Journal of Medical & Health Sciences, 17(01), 767-767.
Grossmann, M., Wierman, M. E., Angus, P., & Handelsman, D. J. (2019). Reproductive endocrinology of nonalcoholic fatty liver disease. Endocrine reviews, 40(2), 417-446.
Hennekens, C. H., Evans, D. A., Castelli, W. P., Taylor, J. O., Rosner, B., & Kass, E. H. (1979). Oral contraceptive use and fasting triglyceride, plasma cholesterol and HDL cholesterol. Circulation, 60(3), 486-489.
Littlejohn, K. E. (2013). “It’s those Pills that are Ruining Me” Gender and the Social Meanings of Hormonal Contraceptive Side Effects. Gender & Society, 27(6), 843-863.
Mangan, S. A., Larsen, P. G., & Hudson, S. (2002). Overweight teens at increased risk for weight gain while using depot medroxyprogesterone acetate. Journal of Pediatric and Adolescent Gynecology, 15(2), 79-82.
Manzoor, S., Ganie, M. A., Majid, S., Shabir, I., Kawa, I. A., Fatima, Q., ... & Rashid, F. (2021). Analysis of intrinsic and extrinsic coagulation pathway factors in OCP treated PCOS women. Indian Journal of Clinical Biochemistry, 36, 278-287.
Martell, S., Marini, C., Kondas, C. A., & Deutch, A. B. (2023). Psychological side effects of hormonal contraception: a disconnect between patients and providers. Contraception and reproductive medicine, 8(1), 9. https://doi.org/10.1186/s40834-022-00204-w
Noori, F. R., & Althanoon, Z. A. (2022). Effects Of Estrogen and Progesterone Used in Oral Contraceptive Pills: A review. Iraqi Journal of Pharmacy, 19(1), 134-146.
Noori, F. R., & Althanoon, Z. A. (2022). Effects Of Estrogen and Progesterone Used in Oral Contraceptive Pills: A review. Iraqi Journal of Pharmacy, 19(1), 134-146.
Palacios, S., Regidor, P. A., Colli, E., Skouby, S. O., Apter, D., Roemer, T., ... & Bitzer, J. (2020). Oestrogen-free oral contraception with a 4 mg drospirenone-only pill: new data and a review of the literature. The European Journal of Contraception & Reproductive Health Care, 25(3), 221-227.
Sathar, Z., Singh, S., Hussain, S., & Sadiq, M. (2023). Financing gaps for Pakistan's contraceptive prevalence goals: Analyses using the Guttmacher adding-it-up methodology. Contraception, 118, 109910.
Shiferaw, M., Kassahun, W., & Zawdie, B. (2021). Anthropometric indices, blood pressure, and lipid profile status among women using progestin-only contraceptives: comparative cross-sectional study. BMC Women's Health, 21(1), 1-9.
Solanki, R., Patel, H. C., & Kosambiya, J. K. (2017). Identify determinant of contraceptive use in rural set up of Surat district, Gujarat. International Journal of Community Medicine and Public Health, 4(8), 2956.
Turner, A. M., Donelan, E. A., & Kiley, J. W. (2019). Contraceptive options following gestational diabetes: Current perspectives. Open Access Journal of Contraception, 41-53.
Vandenbroucke, J. P., Van Der Meer, F. J., Helmerhorst, F. M., & Rosendaal, F. R. (1996). Factor V Leiden: should we screen oral contraceptive users and pregnant women?. Bmj, 313(7065), 1127-1130.
Watkins, E. S. (2012). How the pill became a lifestyle drug: the pharmaceutical industry and birth control in the United States since 1960. American journal of public health, 102(8), 1462-1472.
Yoon, C. W., & Bushnell, C. D. (2023). Stroke in women: a review focused on epidemiology, risk factors, and outcomes. Journal of Stroke, 25(1), 2-15.
Yousuf, S. D., Rashid, F., Mattoo, T., Shekhar, C., Mudassar, S., Zargar, M. A., & Ganie, M. A. (2017). Does the oral contraceptive pill increase plasma intercellular adhesion molecule-1, monocyte chemoattractant protein-1, and tumor necrosis factor-α levels in women with polycystic ovary syndrome: a pilot study. Journal of pediatric and adolescent gynecology, 30(1), 58-62.
Published
How to Cite
Issue
Section
Copyright (c) 2023 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
